Revenue

Appdome's new DefenseOS aims to end the conflict between app security and performance, offering a dedicated execution engine for mobile defenses.

StatSocial's new Substack integration gives marketers unprecedented access to the newsletter economy's valuable, high-intent audiences. What does it mean?

Federal banks are funding Quebec's massive Matawinie mine, a strategic move to power North America's EV industry and challenge global supply chains.

Consumers overcharged for generic drugs may get cash from a new $17.8M settlement. Find out if you're eligible and how this fits into a larger legal war.

A new SHEIN survey reveals Gen Z's multi-outfit festival craze. But as the fast-fashion giant cashes in, its strategy faces mounting ethical scrutiny.

A new Philadelphia facility from Bill Gates' TerraPower aims to increase production of a rare cancer-fighting isotope by 20-fold, breaking a major bottleneck.

Boston-based PhaseV unveils its AI Conductor, a new platform designed to automate the entire clinical trial lifecycle and accelerate FDA submissions.

Akur8 expands into life insurance by acquiring Slope Software, signaling a major shift in the actuarial tech landscape toward unified, AI-driven platforms.

After regaining Nasdaq compliance, Incannex Healthcare is leveraging its $75M war chest to advance novel treatments for sleep apnea and anxiety.

Belgian firm Endo Tools Therapeutics wins US approval for its next-gen endomina® EZFuse, a device promising to cut GI procedure times by up to 50%.

A new collaboration will use Voro's 'masking' technology to create tumor-activated ADCs, aiming to make powerful cancer therapies safer and more effective.

Brazil's largest holding company announces a historic 11% profit increase, a 59% shareholder return, and massive payouts, all amid high interest rates.

A new partnership with Socomore positions Blend Supply as a master distributor, promising to streamline access to critical aerospace chemicals in North America.

SiteOne's acquisition of the 150-year-old Reinders signals a major shift in the Midwest landscape supply market and highlights a growing industry trend.

A simple blood test is revolutionizing Alzheimer's diagnosis. ALZpath's pTau217 antibody is now the industry benchmark, promising earlier detection for millions.

As AI valuations soar and IPOs loom, one veteran wealth manager warns of a familiar pattern. Are we witnessing innovation or another dot-com-style bubble?

A strategic investment positions Wilkerson Crane Rental to dominate the booming Midwest construction and infrastructure market.

Amid a global scramble for critical minerals, one company's advanced airborne tech promises faster, greener, and more secure resource discovery.

Houston-based Americana Partners hires an M&A expert as its new CFO, signaling a strategic push to accelerate its already rapid national expansion.

A new study reveals over 211 fake legal cases, largely AI-generated, have infiltrated Canadian courts, threatening justice and hitting the vulnerable hardest.